High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma-Reference-Cited by-同舟云学术

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Published:2018-05-03 Issue:18 Volume:131 Page:2086-2089
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Schrader Anne M. R.¹,Jansen Patty M.¹,Willemze Rein²,Vermeer Maarten H.²,Cleton-Jansen Anne-Marie¹,Somers Sebastiaan F.³,Veelken Hendrik³,van Eijk Ronald¹,Kraan Willem⁴,Kersten Marie José⁵,van den Brand Michiel⁴,Stevens Wendy B. C.⁶,de Jong Daphne⁷,Abdul Hamid Myrurgia⁸,Tanis Bea C.⁹,Posthuma Eduardus F. M.¹⁰,Nijland Marcel¹¹,Diepstra Arjan¹²,Pals Steven T.⁴,Cleven Arjen H. G.¹,Vermaat Joost S. P.³

Affiliation:

1. Department of Pathology,

2. Department of Dermatology, and

3. Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;

4. Department of Pathology and

5. Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands;

6. Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands;

7. Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands;

8. Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands;

9. Department of Internal Medicine, Groene Hart Ziekenhuis, Gouda, The Netherlands;

10. Department of Internal Medicine, Reinier de Graaf Group, Delft, The Netherlands; and

11. Department of Hematology and

12. Department of Pathology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/131/18/2086/1405591/blood822817.pdf

Reference25 articles.

1. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues;Swerdlow,2017

2. Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions;Ferreri;Haematologica,2007

3. Intravascular lymphoma: clinical presentation, natural history, management and prognostic factors in a series of 38 cases, with special emphasis on the ‘cutaneous variant’;Ferreri;Br J Haematol,2004

4. The addition of rituximab to anthracycline-based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B-cell lymphoma;Ferreri;Br J Haematol,2008

5. Retrospective analysis of intravascular large B-cell lymphoma treated with rituximab-containing chemotherapy as reported by the IVL study group in Japan;Shimada;J Clin Oncol,2008

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous B-Cell Lymphomas;Hematology/Oncology Clinics of North America;2024-10

2. Plasma circulating tumour DNA is a better source for diagnosis and mutational analysis of IVLBCL than tissue DNA;Journal of Cellular and Molecular Medicine;2024-07

3. Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5 ⁺ diffuse large-B cell lymphoma;Journal of Chemotherapy;2024-04-23

4. Cutaneous Intravascular Hematolymphoid Entities: A Review;Diagnostics;2024-03-23

5. The Genetic Profile of Large B-Cell Lymphomas Presenting in the Ocular Adnexa;International Journal of Molecular Sciences;2024-03-07